Keith is a scientist/entrepreneur in the for-profit and non-profit biomedical space, and has co-founded more than a dozen companies. He was a founder and Executive Director of the i2b2 tranSMART Foundation, he founded the Systems Biology program at CHDI Foundation, and he was Chief Commercial Officer at Curoverse. He has also been the founder and CEO or CSO of biotechnology companies in the areas of biomedical computing, artificial intelligence, systems biology, and genomics. He has spent his career in the pharmaceutical (Merck and Bayer) and biotechnology (Gene Logic, Viaken, Genstruct/Selventa) industries, and in the non-profit (CHDI, tranSMART, i2b2 tranSMART Foundations) space.

Steve is an experienced finance and strategy executive, and has served as VP of Finance and/or CFO for numerous public and private companies including PricewaterhouseCoopers, Avid Technology, Panviva, Abiomed, Punchey, Inc.,  and TechCXO. He also has extensive experience with non-profit foundations, and serves on the Finance Committee of the Autism Foundation.

Scott is an experienced healthcare technology executive with deep roots in product development and hospital operations. He has extensive experience having served in leadership roles in Provider and Payor organizations and worked closely with the Life Sciences industry to responsibly monetize patient data for research and clinical trials. He served as the Chief Technology Officer for Optum Analytics (the leader in RWE), CTO for Cancer Treatment Centers of America, and was the CTO for PHEMI Systems. Scott also serve as a company commander in the US Army and Reserves.

Deb’s career has been focused at the intersection of basic and applied health sciences research, bioinformatics, computational biology, and the business of science. She has deep experience commercializing diverse products and services at early-stage start-up companies in the health science ecosystem. Deb has had senior leadership positions at Cellomics, Inc, RedPath Integrated Pathology, Theranostics Health, and Cellumen, Inc. These commercialization efforts include product development, marketing, market and business development and the development, support and execution of B2B sales strategies. Deb also has extensive experience managing the development of diverse database and analytics tools to support drug discovery, AI-based drug discovery, genomics research, biospecimen research, and serological science research.

Peter Rice is a highly-experienced bioinformatician and scientific software developer. Peter has been working as a lead developer on tranSMART since the project became open source in 2013, and was the senior tranSMART developer on the European eTRIKS project (€24M IMI project) and leads the tranSMART development efforts with the i2b2-tranSMART Foundation. Peter is the release manager for tranSMART, and is currently responsible for the new tranSMART 19 release. He serves as a member of the tranSMART PMC and he is also the Foundation data content manager responsible for the postgres and oracle schemas and managing a collection of curated public patient datasets. Peter also manages an Axiomedix i2b2/tranSMART server, several tranSMART servers, and is developing an installer for our i2b2 server. Previously Peter was a senior developer with the European Bioinformatics Institute (EBI), Lion Bioscience, the Wellcome Trust Sanger Institute and the European Molecular Biology Laboratory (EMBL). Peter is the lead developer for the open-source EMBOSS suite for molecular sequence analysis.

As the General Manager of the Axiomedix Health Data Marketplace in Canada, Luticia (Tish) Hill is responsible for overseeing all aspects of operations, strategic planning, and growth initiatives. She is a dynamic and results-driven leader with experience in the Canadian healthcare industry both at the Provincial government level in British Columbia, and at the hospital level in Alberta. Tish understands the Canadian healthcare system, including regulations, policies, and privacy laws related to health data management and sharing. Through her management position at PHEMI Systems in Vancouver, she has proven experience in managing health data projects, data analytics, and health informatics. She holds a Science degree from the University of Victoria in Health Information Science, where she gained experience with healthcare data standards, interoperability, data governance and data security practices.

Dr. Zelalem Temesgen MD is an infectious diseases physician and a Professor of Medicine, Mayo Clinic College of Medicine and Science. He serves as director of the Mayo Clinic HIV program and the Mayo Clinic Center for Tuberculosis as well as being actively involved in education and research. His educational activities have been acknowledged with a “Recognition for Teaching” award, “Best Teacher of the Year” award, an “Innovation in Education” award, and the “Mayo Clinic Distinguished Educator” award, the highest award for education given at Mayo Clinic.

Dr. Temesgen has served as the principal investigator for over 40 clinical trials, including as site principal investigator (PI) for several NIH-sponsored trials in HIV, influenza, COVID-19, and c. difficile infections. Additional research-related experience includes several years’ service as a member of the Mayo Clinic Institutional Review Board (IRB) and membership in as well as chairing Data and Safety Monitoring Boards. His bibliography currently lists over 180 peer-reviewed papers, 21 book chapters, 4 editorials, 2 indexed letters, 3 books, and numerous abstracts presented at professional meetings. Dr. Temesgen is the editor-in-chief of the Clinical Journal of Tuberculosis and other Mycobacterial Diseases and editor-in-chief of 3 books: Mayo Clinic Infectious Diseases Board Review Book; Fundamentals of Global HIV Medicine; and General Approach to Infectious Diseases.

Dr. Temesgen serves as a member of: US DHHS Advisory Council for the Elimination of Tuberculosis and the World Health Organization Taskforce on Digital Health for Tuberculosis. Past services include: Chair, American Academy of HIV Medicine; member, US Presidential Advisory Council on HIV/AIDS; member, Lancet Commission on Tuberculosis; member, DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents; member, Scientific Advisory Board for the US President’s Emergency Plan for AIDS Relief (PEPFAR); and member the National Board of Medical Examiners USMLE Microbiology & Immunology Test Material Development Committee.